Steve Scala
Stock Analyst at TD Cowen
(4.50)
# 1,070
Out of 5,055 analysts
405
Total ratings
62.7%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Reiterated: Buy | $1,250 | $1,208.74 | +3.41% | 49 | Oct 1, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $283.48 | -1.23% | 43 | Sep 28, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $137 → $155 | $147.37 | +5.18% | 32 | Sep 22, 2026 | |
| NVS Novartis AG | Reiterated: Hold | $180 | $146.88 | +22.55% | 36 | Sep 8, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 18,092p | 12,300p | +47.09% | 9 | Aug 31, 2026 | |
| SNY Sanofi | Reiterated: Hold | $57 | $39.77 | +43.32% | 26 | Aug 31, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $32 | $22.55 | +41.91% | 18 | Aug 25, 2026 | |
| ZTS Zoetis | Rated: Buy | $104 → $94 | $75.29 | +24.85% | 25 | Aug 25, 2026 | |
| PFE Pfizer | Reiterated: Hold | n/a | $29.21 | - | 44 | Aug 11, 2026 | |
| GSK GSK plc | Reiterated: Hold | $70 | $47.87 | +46.23% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $253.91 | +18.15% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $55.69 | +20.31% | 27 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8 | $12.64 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $54 | $59.28 | n/a | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $15 | $13.74 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17.11 | $8.40 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $58.99 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.54 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.12 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 96.59 → CHF 109.47 | CHF 122.66 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $38.12 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,250p → 1,790p | 1,816p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 370.90 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €41.33 → €98.00 | €71.82 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.19 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €67.17 → €76.76 | €141.90 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $426.11 | n/a | 2 | Oct 3, 2017 |
Eli Lilly and Company
Oct 1, 2026
Reiterated: Buy
Price Target: $1,250
Current: $1,208.74
Upside: +3.41%
AbbVie
Sep 28, 2026
Reiterated: Buy
Price Target: $280
Current: $283.48
Upside: -1.23%
Merck & Co.
Sep 22, 2026
Reiterated: Hold
Price Target: $137 → $155
Current: $147.37
Upside: +5.18%
Novartis AG
Sep 8, 2026
Reiterated: Hold
Price Target: $180
Current: $146.88
Upside: +22.55%
AstraZeneca PLC
Aug 31, 2026
Reiterated: Buy
Price Target: 18,092p
Current: 12,300p
Upside: +47.09%
Sanofi
Aug 31, 2026
Reiterated: Hold
Price Target: $57
Current: $39.77
Upside: +43.32%
Elanco Animal Health
Aug 25, 2026
Rated: Buy
Price Target: $32
Current: $22.55
Upside: +41.91%
Zoetis
Aug 25, 2026
Rated: Buy
Price Target: $104 → $94
Current: $75.29
Upside: +24.85%
Pfizer
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $29.21
Upside: -
GSK plc
Aug 3, 2026
Reiterated: Hold
Price Target: $70
Current: $47.87
Upside: +46.23%
Jul 13, 2026
Reiterated: Buy
Price Target: $300
Current: $253.91
Upside: +18.15%
Apr 23, 2026
Reiterated: Hold
Price Target: $67
Current: $55.69
Upside: +20.31%
Aug 7, 2025
Reiterated: Hold
Price Target: $9 → $8
Current: $12.64
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $64 → $54
Current: $59.28
Upside: n/a
Apr 22, 2025
Reiterated: Hold
Price Target: $19 → $15
Current: $13.74
Upside: n/a
Feb 21, 2025
Reiterated: Hold
Price Target: $17.11
Current: $8.40
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $58.99
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.54
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
Nov 11, 2024
Reiterated: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 122.66
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $38.12
Upside: n/a
Nov 30, 2023
Reiterated: Hold
Price Target: 2,250p → 1,790p
Current: 1,816p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 370.90
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €41.33 → €98.00
Current: €71.82
Upside: n/a
Jun 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $4.19
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €67.17 → €76.76
Current: €141.90
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $426.11
Upside: n/a